Applied DNA Sciences Inc Retained Earnings (Accumulated Deficit) 2010-2024 | APDN
Applied DNA Sciences Inc retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Applied DNA Sciences Inc Annual Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2023 |
$-302 |
| 2022 |
$-293 |
| 2021 |
$-284 |
| 2020 |
$-270 |
| 2019 |
$-257 |
| 2018 |
$-248 |
| 2017 |
$-237 |
| 2016 |
$-224 |
| 2015 |
$-212 |
| 2014 |
$-200 |
| 2013 |
$-187 |
| 2012 |
$-169 |
| 2011 |
$-162 |
| 2010 |
$-151 |
| 2009 |
$-143 |
Applied DNA Sciences Inc Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2024-06-30 |
$-306 |
| 2024-03-31 |
$-308 |
| 2023-12-31 |
$-304 |
| 2023-09-30 |
$-302 |
| 2023-06-30 |
$-299 |
| 2023-03-31 |
$-296 |
| 2022-12-31 |
$-296 |
| 2022-09-30 |
$-293 |
| 2022-06-30 |
$-292 |
| 2022-03-31 |
$-291 |
| 2021-12-31 |
$-289 |
| 2021-09-30 |
$-284 |
| 2021-06-30 |
$-280 |
| 2021-03-31 |
$-276 |
| 2020-12-31 |
$-275 |
| 2020-09-30 |
$-270 |
| 2020-06-30 |
$-266 |
| 2020-03-31 |
$-262 |
| 2019-12-31 |
$-259 |
| 2019-09-30 |
$-257 |
| 2019-06-30 |
$-255 |
| 2019-03-31 |
$-254 |
| 2018-12-31 |
$-251 |
| 2018-09-30 |
$-248 |
| 2018-06-30 |
$-245 |
| 2018-03-31 |
$-242 |
| 2017-12-31 |
$-240 |
| 2017-09-30 |
$-237 |
| 2017-06-30 |
$-234 |
| 2017-03-31 |
$-231 |
| 2016-12-31 |
$-228 |
| 2016-09-30 |
$-224 |
| 2016-06-30 |
$-221 |
| 2016-03-31 |
$-218 |
| 2015-12-31 |
$-215 |
| 2015-09-30 |
$-212 |
| 2015-06-30 |
$-211 |
| 2015-03-31 |
$-209 |
| 2014-12-31 |
$-208 |
| 2014-09-30 |
$-200 |
| 2014-06-30 |
$-198 |
| 2014-03-31 |
$-196 |
| 2013-12-31 |
$-193 |
| 2013-09-30 |
$-187 |
| 2013-06-30 |
$-183 |
| 2013-03-31 |
$-181 |
| 2012-12-31 |
$-178 |
| 2012-09-30 |
$-169 |
| 2012-06-30 |
$-167 |
| 2012-03-31 |
$-166 |
| 2011-12-31 |
$-164 |
| 2011-09-30 |
$-162 |
| 2011-06-30 |
$-157 |
| 2011-03-31 |
$-155 |
| 2010-12-31 |
$-153 |
| 2010-09-30 |
$-151 |
| 2010-06-30 |
$-149 |
| 2010-03-31 |
$-147 |
| 2009-12-31 |
$-145 |
| 2009-09-30 |
$-143 |
| 2009-06-30 |
$-142 |
| 2009-03-31 |
$-141 |
| Sector |
Industry |
Market Cap |
Revenue |
| Industrial Products |
Protection - Safety Equipment & Services |
$0.005B |
$0.013B |
|
Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion. They develop, market, and sub-license DNA security systems, supply-chain management systems and anti-counterfeit solutions. Applied DNA Sciences has an exclusive licensing and partnership agreement covering North America and Europe with Biowell Technology, Inc. of Taiwan.
|
